Picard Medical, Inc. (PMI)

Picard Medical will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Chart not available yet
Data will show when the stock starts trading.
Market Cap n/a
Revenue (ttm) 4.39M
Net Income (ttm) -23.74M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About PMI

Picard Medical owns 100% of the membership interests of SynCardia Systems. SynCardia is a medical technology company that manufactures and sells the only U.S. Food and Drug Administration, and Health Canada approved implantable total artificial heart (the “SynCardia TAH”). To date, over 2,100 SynCardia TAHs have been implanted in patients in 27 countries and the SynCardia TAH is an established bridge to heart transplantation for patients with biventricular failure in the U.S., and around the world. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1981
Employees 75
Stock Exchange NYSEAMERICAN
Ticker Symbol PMI
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

SynCardia artificial heart maker Picard Medical plans to go public

Picard Medical, which owns and operates the implant manufacturer SynCardia, aims to list on the New York Stock Exchange under the ticker PMI.

17 days ago - Fierce BioTech

Artificial heart maker Picard Medical files for a $12 million IPO

Picard Medical, which makes and sells implantable total artificial hearts under the brand SynCardia, filed on Tuesday with the SEC to raise up to $12 million in an initial public offering.

18 days ago - Renaissance Capital

Picard Medical IPO Registration Document (S-1)

Picard Medical has filed to go public with an IPO on the NYSE American.

18 days ago - SEC